India Observers

Top Menu

  • Twitter
  • Youtube
  • Facebook
  • Instagram
  • Medium
  • Reddit
  • Blogspot
  • Facebook group

Main Menu

  • Latest
  • News
    • National
    • International
  • Political
  • Business
    • Finance
  • Technology
    • Gadgets
  • Entertainment
  • Sports
    • Cricket
    • Football
    • Others
  • Lifestyle
    • Health
    • Fitness
    • Fashion
    • Travel
  • Twitter
  • Youtube
  • Facebook
  • Instagram
  • Medium
  • Reddit
  • Blogspot
  • Facebook group
logo

India Observers

  • Latest
  • News
    • National
    • International
  • Political
  • Business
    • Finance
  • Technology
    • Gadgets
  • Entertainment
  • Sports
    • Cricket
    • Football
    • Others
  • Lifestyle
    • Health
    • Fitness
    • Fashion
    • Travel
  • Tata Curvv EV Launch Date Confirmed: Price Expectations, Range, Battery Specs, and Feature Upgrades

  • Did OpenAI’s AI Agents Really Go Rogue? Separating Hype From Reality

  • TCS-NVIDIA AI Hub Explained: Autonomous Engineering, Industrial Automation and Key Benefits

  • Sony FX5 Cinema Camera Launched: Open Gate Recording, AI Autofocus and Key Features Explained

  • Truvora AI Launches Independent Discovery Platform to Evaluate AI Tools Across Categories

Tag: Type 1 Diabetes

Home›Posts Tagged "Type 1 Diabetes"
  • novo nordisk awiqli india
    HealthLifestyle
    By Political Writer
    July 10, 2026
    10
    0

    Novo Nordisk Launches Weekly Insulin Awiqli in India: Benefits, Dosage and Eligibility Explained

    A new landmark has been created by India in its battle against diabetes with the advent of the first once-a-week basal insulin called Awiqli (insulin icodec). This new insulin injection will significantly lessen the burden of daily injections for millions of adult patients with diabetes, substituting for 365 injections per year with just 52 injections ...
    Read More

https://indiaobservers.com/wp-content/uploads/2023/03/Logo-Google-News.png

Follow Us

Quick Links

About us | Privacy Policy | Terms and Conditions

Navigation

Sitemap Contact Us Top 10

Follow Us on Facebook

© Copyright 2026- India Observers.